4 not yet recruiting, 1 recruiting. 4 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 4 |
| Not applicable | 1 | Recruiting 1 |
Follow Retlirafusp alfa: new trials by email Literature Review of Retlirafusp alfa trials Research Report on Retlirafusp alfa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retlirafusp Alfa Combined With Zeprumetostat, Apatinib, and Chemotherapy as First-Line Treatment for Metastatic GC/GEJC Retlirafusp alfa, zeprumetostat, apatinib - Gastric Cancer/Gastroesophageal Junction Adenocarcinoma | Phase 2 | Not yet recruiting | Fudan University | 55 | 2026-10-01 | 2026-10-14 |
| Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma Retlirafusp Alfa, Oxaliplatin, Capecitabine - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Not yet recruiting | Tang-Du Hospital | 21 | 2026-08-30 | 2026-07-17 |
| Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer Retlirafusp Alfa, Apatinib, Fluoropyrimidine-Based Chemotherapy - Pancreatic Cancer | Phase 2 | Not yet recruiting | Tang-Du Hospital | 37 | 2026-08-30 | 2026-08-19 |
| Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC Retlirafusp alfa, Nab paclitaxel, Cisplatin for injection - Esophageal Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | Tang-Du Hospital | 33 | 2026-05-30 | 2026-06-01 |
| Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma FOLFOX4, Adebrelimab, Apatinib - Hepatocellular Carcinoma(HCC) | Not applicable | Recruiting | Nanjing Tianyinshan Hospital | 270 | 2025-05-22 | 2026-10-01 |
Stomach Neoplasms (2) · Carcinoma, Hepatocellular (1) · Esophageal Squamous Cell Carcinoma (1) · Pancreatic Neoplasms (1)
Tang-Du Hospital (3) · Fudan University (1) · Nanjing Tianyinshan Hospital (1)
China (2)